| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT02836184 |
| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P582 | end time | 2016-09-01 | |
| P4135 | maximum age | 80 | |
| P1050 | medical condition | hyperphosphatemia | Q1641062 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 45 | |
| P4844 | research intervention | calcium carbonate | Q23767 |
| nicotinic acid | Q134658 | ||
| niacinamide | Q192423 | ||
| calcium oxalate | Q412399 | ||
| P1813 | short name | NAHPH | |
| P580 | start time | 2016-07-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | The Efficacy and Safety of Nicotinic Acid in the Hemodialysis Patients With Hyperphosphatemia |